Association Between Higher Cumulative Doses of Recombinant Erythropoietin and Risk for Retinopathy of Prematurity
Authors:
- Mark S. BrownMBMark S. Brown
- Anna E. BarónABAnna E. Barón
- Eric K. FranceEFEric K. France
- Richard F. HammanRHRichard F. Hamman
- 1 April 2006
- journal article
- conference paper
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 10 (2) , 143-149
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Erythropoietin regulates endothelial progenitor cellsBlood, 2004
- Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilizationBlood, 2003
- Effects of Early Erythropoietin Therapy on the Transfusion Requirements of Preterm Infants Below 1250 Grams Birth Weight: A Multicenter, Randomized, Controlled TrialPediatrics, 2001
- A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in MiceJournal of Cerebral Blood Flow & Metabolism, 1999
- Effect of recombinant human erythropoietin on endothelial cell apoptosisKidney International, 1999
- Erythropoietin Prevents Place Navigation Disability and Cortical Infarction in Rats with Permanent Occlusion of the Middle Cerebral ArteryBiochemical and Biophysical Research Communications, 1998
- Recombinant human erythropoietin stimulates angiogenesis in vitroKidney International, 1995
- A Cohort Study of Transcutaneous Oxygen Tension and the Incidence and Severity of Retinopathy of PrematurityNew England Journal of Medicine, 1992
- Clinical factors associated with retinopathy of prematurity.Archives of Disease in Childhood, 1988
- Multinomial regression models based on continuation ratiosStatistics in Medicine, 1988